Integrated Wealth Concepts’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
7,616
+4,890
+179% +$901K 0.01% 931
2025
Q4
$480K Sell
2,726
-1,661
-38% -$271K 0.01% 1116
2025
Q3
$614K Buy
4,387
+698
+19% +$94.3K 0.01% 1240
2025
Q2
$463K Buy
3,689
+1,609
+77% +$200K ﹤0.01% 1322
2025
Q1
$285K Sell
2,080
-2,399
-54% -$343K ﹤0.01% 1432
2024
Q4
$685K Buy
4,479
+2,908
+185% +$490K 0.01% 984
2024
Q3
$305K Sell
1,571
-2,485
-61% -$520K ﹤0.01% 1337
2024
Q2
$940K Buy
4,056
+486
+14% +$106K 0.01% 786
2024
Q1
$770K Buy
3,570
+1,556
+77% +$364K 0.01% 864
2023
Q4
$521K Sell
2,014
-315
-14% -$77.4K 0.01% 985
2023
Q3
$599K Buy
2,329
+682
+41% +$182K 0.01% 904
2023
Q2
$469K Sell
1,647
-1,349
-45% -$402K 0.01% 1006
2023
Q1
$833K Buy
+2,996
New +$829K 0.02% 687
2022
Q3
Sell
-2,010
Closed -$410K 953
2022
Q2
$410K Buy
+2,010
New +$411K 0.01% 662

Other funds holding BIIB

Integrated Wealth Concepts's BIIB Position: Q1 2026 in Review

Integrated Wealth Concepts increased its Biogen (BIIB) stake by 179% in Q1 2026, buying an estimated $901K and bringing the position to 7,616 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #931.

Integrated Wealth Concepts first reported a position in BIIB in Q2 2022 and has held it in 14 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Integrated Wealth Concepts held 7,616 shares of Biogen worth $1.4M as of Q1 2026.
  • Integrated Wealth Concepts bought 4,890 Biogen shares in Q1 2026, an estimated $901K.
  • Biogen made up 0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #931 holding.
  • Integrated Wealth Concepts first reported a position in Biogen in Q2 2022 and has held it in 14 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.